Skip to main content
Erschienen in: Strahlentherapie und Onkologie 4/2013

01.04.2013 | Original article

Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins

Different alignment techniques in 3D conformal prostate cancer radiotherapy

verfasst von: Prof. T. Langsenlehner, M.D., C. Döller, P. Winkler, G. Gallé, K.S. Kapp

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this work was to analyze interfraction and intrafraction deviations and residual set-up errors (RSE) after online repositioning to determine PTV margins for 3 different alignment techniques in prostate cancer radiotherapy.

Methods

The present prospective study included 44 prostate cancer patients with implanted fiducials treated with three-dimensional (3D) conformal radiotherapy. Daily localization was based on skin marks followed by marker detection using kilovoltage (kV) imaging and subsequent patient repositioning. Additionally, in-treatment megavoltage (MV) images were obtained for each treatment field. In an off-line analysis of 7,273 images, interfraction prostate motion, RSE after marker-based prostate localization, prostate position during each treatment session, and the effect of treatment time on intrafraction deviations were analyzed to evaluate PTV margins.

Results

Margins accounting for interfraction deviation, RSE and intrafraction motion were 14.1, 12.9, and 15.1 mm in anterior–posterior (AP), superior–inferior (SI), and left–right (LR) direction for skin mark alignment and 9.6, 8.7, and 2.6 mm for bony structure alignment, respectively. Alignment to implanted markers required margins of 4.6, 2.8, and 2.5 mm. As margins to account for intrafraction motion increased with treatment prolongation PTV margins could be reduced to 3.9, 2.6, and 2.4 mm if treatment time was ≤ 4 min.

Conclusion

With daily online correction and repositioning based on implanted fiducials, a significant reduction of PTV margins can be achieved. The use of an optimized workflow with faster treatment techniques such as volumetric modulated arc techniques (VMAT) could allow for a further decrease.
Literatur
1.
Zurück zum Zitat Adamson J, Wu Q, Yan D (2011) Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance. Int J Radiat Oncol Biol Phys 80:453–461PubMedCrossRef Adamson J, Wu Q, Yan D (2011) Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance. Int J Radiat Oncol Biol Phys 80:453–461PubMedCrossRef
2.
Zurück zum Zitat Al-Mamgani A, van Putten WL, Heemsbergen WD et al (2008) Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72:980–988PubMedCrossRef Al-Mamgani A, van Putten WL, Heemsbergen WD et al (2008) Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72:980–988PubMedCrossRef
3.
Zurück zum Zitat Budiharto T, Slagmolen P, Haustermans K et al (2011) Intrafractional prostate motion during online image guided intensity-modulated radiotherapy for prostate cancer. Radiother Oncol 98:181–186PubMedCrossRef Budiharto T, Slagmolen P, Haustermans K et al (2011) Intrafractional prostate motion during online image guided intensity-modulated radiotherapy for prostate cancer. Radiother Oncol 98:181–186PubMedCrossRef
4.
Zurück zum Zitat Curtis W, Khan M, Magnelli A et al (2013) Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data. Int J Radiat Oncol Biol Phys 85:700–706PubMedCrossRef Curtis W, Khan M, Magnelli A et al (2013) Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data. Int J Radiat Oncol Biol Phys 85:700–706PubMedCrossRef
5.
Zurück zum Zitat de Crevoisier R, Tucker SL, Dong L et al (2005) Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62:965–973CrossRef de Crevoisier R, Tucker SL, Dong L et al (2005) Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62:965–973CrossRef
6.
Zurück zum Zitat Deutschmann H, Kametriser G, Steininger P et al (2012) First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapyto correct for inter- and intrafractional rotations of the prostate. Int J Radiat Oncol Biol Phys 83:1624–1632PubMedCrossRef Deutschmann H, Kametriser G, Steininger P et al (2012) First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapyto correct for inter- and intrafractional rotations of the prostate. Int J Radiat Oncol Biol Phys 83:1624–1632PubMedCrossRef
7.
Zurück zum Zitat Fuller CD, Thomas CR, Schwartz S et al (2006) Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting. Phys Med Biol 51:4981–4993PubMedCrossRef Fuller CD, Thomas CR, Schwartz S et al (2006) Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting. Phys Med Biol 51:4981–4993PubMedCrossRef
8.
Zurück zum Zitat Geier M, Astner ST, Duma MN et al (2012) Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy. Strahlenther Onkol 188:410–416PubMedCrossRef Geier M, Astner ST, Duma MN et al (2012) Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy. Strahlenther Onkol 188:410–416PubMedCrossRef
9.
Zurück zum Zitat Graf R, Boehmer D, Budach V et al (2010) Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials. Strahlenther Onkol 186:544–550PubMedCrossRef Graf R, Boehmer D, Budach V et al (2010) Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials. Strahlenther Onkol 186:544–550PubMedCrossRef
10.
Zurück zum Zitat Heemsbergen WD, Hoogeman MS, Witte MG et al (2007) Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 GY versus 78 Gy. Int J Radiat Oncol Biol Phys 67:1418–1424PubMedCrossRef Heemsbergen WD, Hoogeman MS, Witte MG et al (2007) Increased risk of biochemical and clinical failure for prostate patients with a large rectum at radiotherapy planning: results from the Dutch trial of 68 GY versus 78 Gy. Int J Radiat Oncol Biol Phys 67:1418–1424PubMedCrossRef
11.
Zurück zum Zitat Hoogeman MS, van Herk M, de Bois J et al (2005) Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol 74:177–185PubMedCrossRef Hoogeman MS, van Herk M, de Bois J et al (2005) Strategies to reduce the systematic error due to tumor and rectum motion in radiotherapy of prostate cancer. Radiother Oncol 74:177–185PubMedCrossRef
12.
Zurück zum Zitat Kotte AN, Hofman P, Lagendijk JJ et al (2007) Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys 69:419–425PubMedCrossRef Kotte AN, Hofman P, Lagendijk JJ et al (2007) Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers. Int J Radiat Oncol Biol Phys 69:419–425PubMedCrossRef
13.
Zurück zum Zitat Kuban DA, Tucker SL, Dong L et al (2008) Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70:67–74PubMedCrossRef Kuban DA, Tucker SL, Dong L et al (2008) Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70:67–74PubMedCrossRef
14.
Zurück zum Zitat Kupelian P, Willoughby T, Mahadevan A et al (2007) Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 67:1088–1098PubMedCrossRef Kupelian P, Willoughby T, Mahadevan A et al (2007) Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 67:1088–1098PubMedCrossRef
15.
Zurück zum Zitat Langen KM, Jones DT (2001) Organ motion and its management. Int J Radiat Oncol Biol Phys 50:265–278PubMedCrossRef Langen KM, Jones DT (2001) Organ motion and its management. Int J Radiat Oncol Biol Phys 50:265–278PubMedCrossRef
16.
Zurück zum Zitat Li JS, Jin L, Pollack A et al (2009) Gains from real-time tracking of prostate motion during external beam radiation therapy. Int J Radiat Oncol Biol Phys 75:1613–1620PubMedCrossRef Li JS, Jin L, Pollack A et al (2009) Gains from real-time tracking of prostate motion during external beam radiation therapy. Int J Radiat Oncol Biol Phys 75:1613–1620PubMedCrossRef
17.
Zurück zum Zitat Liang J, Wu Q, Yan D (2009) The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 73:935–943PubMedCrossRef Liang J, Wu Q, Yan D (2009) The role of seminal vesicle motion in target margin assessment for online image-guided radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 73:935–943PubMedCrossRef
18.
Zurück zum Zitat Litzenberg DW, Balter JM, Hadley SW et al (2012) Prostate intrafraction translation margins for real-time monitoring and correction strategies. Prostate Cancer 2012:130579PubMedCrossRef Litzenberg DW, Balter JM, Hadley SW et al (2012) Prostate intrafraction translation margins for real-time monitoring and correction strategies. Prostate Cancer 2012:130579PubMedCrossRef
19.
Zurück zum Zitat McKenzie AL, Coffey M, Greener T et al (2003) Technical overview of geometric uncertainties in radiotherapy. In Geometric Uncertainties in Radiotherapy. Br Ins Radiol 11–45 McKenzie AL, Coffey M, Greener T et al (2003) Technical overview of geometric uncertainties in radiotherapy. In Geometric Uncertainties in Radiotherapy. Br Ins Radiol 11–45
20.
Zurück zum Zitat Mutanga TF, de Boer HC, Rajan V et al (2012) Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment. Int J Radiat Oncol Biol Phys 83:400–407PubMedCrossRef Mutanga TF, de Boer HC, Rajan V et al (2012) Day-to-day reproducibility of prostate intrafraction motion assessed by multiple kV and MV imaging of implanted markers during treatment. Int J Radiat Oncol Biol Phys 83:400–407PubMedCrossRef
21.
Zurück zum Zitat Mutanga TF, de Boer HC, van der Wielen GJ et al (2011) Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections. Int J Radiat Oncol Biol Phys 81:1160–1167PubMedCrossRef Mutanga TF, de Boer HC, van der Wielen GJ et al (2011) Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections. Int J Radiat Oncol Biol Phys 81:1160–1167PubMedCrossRef
22.
Zurück zum Zitat Olsen JR, Noel CE, Baker K et al (2012) Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking. Int J Radiat Oncol Biol Phys 82:1903–1911PubMedCrossRef Olsen JR, Noel CE, Baker K et al (2012) Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking. Int J Radiat Oncol Biol Phys 82:1903–1911PubMedCrossRef
23.
Zurück zum Zitat Pasler M, Georg D, Wirtz H et al (2011) Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer. Strahlenther Onkol 187:792–798PubMedCrossRef Pasler M, Georg D, Wirtz H et al (2011) Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer. Strahlenther Onkol 187:792–798PubMedCrossRef
24.
Zurück zum Zitat Peeters ST, Heemsbergen WD, Koper PC et al (2006) Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24:1990–1996PubMedCrossRef Peeters ST, Heemsbergen WD, Koper PC et al (2006) Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24:1990–1996PubMedCrossRef
25.
Zurück zum Zitat Pinkawa M, Piroth MD, Holy R et al (2011) Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol 187:479–484PubMedCrossRef Pinkawa M, Piroth MD, Holy R et al (2011) Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol 187:479–484PubMedCrossRef
26.
Zurück zum Zitat Prokic V, Geinitz H, Kneschaurek P (2012) Reduction of dosimetric impact of intrafractional prostate motion during helical tomotherapy. Strahlenther Onkol 188:404–409PubMedCrossRef Prokic V, Geinitz H, Kneschaurek P (2012) Reduction of dosimetric impact of intrafractional prostate motion during helical tomotherapy. Strahlenther Onkol 188:404–409PubMedCrossRef
27.
Zurück zum Zitat Rasch C, Steenbakkers R, van Herk M (2005) Target definition in prostate, head, and neck. Semin Radiat Oncol 15:136–145PubMedCrossRef Rasch C, Steenbakkers R, van Herk M (2005) Target definition in prostate, head, and neck. Semin Radiat Oncol 15:136–145PubMedCrossRef
28.
Zurück zum Zitat Rijkhorst EJ, van Herk M, Lebesque JV et al (2007) Strategy for online correction of rotational organ motion for intensity-modulated radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 69:1608–1617PubMedCrossRef Rijkhorst EJ, van Herk M, Lebesque JV et al (2007) Strategy for online correction of rotational organ motion for intensity-modulated radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 69:1608–1617PubMedCrossRef
29.
Zurück zum Zitat Schallenkamp JM, Herman MG, Kruse JJ et al (2005) Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 63:800–811PubMedCrossRef Schallenkamp JM, Herman MG, Kruse JJ et al (2005) Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int J Radiat Oncol Biol Phys 63:800–811PubMedCrossRef
30.
Zurück zum Zitat Tanyi JA, He T, Summers PA et al (2010) Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys 78:1579–1585PubMedCrossRef Tanyi JA, He T, Summers PA et al (2010) Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys 78:1579–1585PubMedCrossRef
31.
Zurück zum Zitat van Herk M, Remeijer P, Rasch C et al (2000) The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47:1121–1135CrossRef van Herk M, Remeijer P, Rasch C et al (2000) The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47:1121–1135CrossRef
32.
Zurück zum Zitat Zelefsky MJ, Levin EJ, Hunt M et al (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:1124–1129PubMedCrossRef Zelefsky MJ, Levin EJ, Hunt M et al (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:1124–1129PubMedCrossRef
33.
Zurück zum Zitat Zietman AL, Bae K, Slater JD et al (2010) Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95–09. J Clin Oncol 28:1106–1111PubMedCrossRef Zietman AL, Bae K, Slater JD et al (2010) Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95–09. J Clin Oncol 28:1106–1111PubMedCrossRef
Metadaten
Titel
Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins
Different alignment techniques in 3D conformal prostate cancer radiotherapy
verfasst von
Prof. T. Langsenlehner, M.D.
C. Döller
P. Winkler
G. Gallé
K.S. Kapp
Publikationsdatum
01.04.2013
Verlag
Springer-Verlag
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 4/2013
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-012-0303-0

Weitere Artikel der Ausgabe 4/2013

Strahlentherapie und Onkologie 4/2013 Zur Ausgabe

Mitteilungen der Fachgesellschaften

Mitteilungen der Fachgesellschaften

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.